25
Publications
1.7K
Citations
20
H-Index
1986
Active since
Affiliations
Mark A. Matulenko is an author at Abbott Fund specializing in medicine, pharmacology, and drug discovery.
Top concepts
MedicinePharmacologyDrug DiscoveryBiochemistryMolecular PharmacologyPharmacotherapyMedicinal ChemistryNatural SciencesNeuropharmacologyChemistry
Publications per year
1986–2023
25
25
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity
Christina K. Baumgartner, Hakimeh Ebrahimi-Nik, Arvin Iracheta‐Vellve et al. · Nature · 2023 · 145 citations · Full text
Discovery of ABT-267, a Pan-Genotypic Inhibitor of HCV NS5A
David A. DeGoey, John T. Randolph, Dachun Liu et al. · Journal of Medicinal Chemistry · 2014 · 126 citations
Rows per page
1–5 of 25